ReviewIndian journal of ophthalmology2015
Primary vitreoretinal lymphoma.
Review in Indian journal of ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Ocular oncology practice guidelines during COVID-19 pandemic-An expert consensus.Indian journal of ophthalmology · 2020Guideline
- Review
- Efficacy of Vitreous Biopsy and Clinical Course in Vitreoretinal Lymphoma: A Single-Center Retrospective Analysis.Journal of clinical medicine · 2026Article
- Intraocular Lymphoma: A Review.Journal of ophthalmic & vision research · 2025Review
- Bilateral primary vitreoretinal lymphoma masquerading as fungal endophthalmitis- a case report.Journal of ophthalmic inflammation and infection · 2024Article
- Multimodal imaging in a case of presumed secondary vitreoretinal lymphoma presenting with inner retina and optic nerve head infiltration.American journal of ophthalmology case reports · 2024Article
- Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.International ophthalmology · 2021Observational
- Primary Malignant Orbital Tumors.Journal of neurological surgery. Part B, Skull base · 2021Article
- Cystoid Macular Oedema as a Presenting Feature of Vitreoretinal Lymphoma.Ocular oncology and pathology · 2020Article
- Lymphoma masquerading as occlusive retinal vasculitis: A case study.American journal of ophthalmology case reports · 2020Article
- The use of anterior segment optical coherence tomography (ASOCT) in demonstrating recurrence of vitreoretinal lymphoma (VRL) in the anterior vitreous.International journal of retina and vitreous · 2019Article
- Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.Clinical ophthalmology (Auckland, N.Z.) · 2019Review
- Intraocular lymphoma.International journal of ophthalmology · 2017Review
- Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study.Blood research · 2015Article
- The great masquerader: primary vitreoretinal lymphoma presenting as white dot syndrome.Romanian journal of ophthalmologyArticle
- Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma.Taiwan journal of ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary vitreoretinal lymphoma (PVRL) is an uncommon, but potentially fatal intraocular malignancy, which may occur with or without primary central nervous system lymphoma (PCNSL). Considered to be a subset of PCNSL, it is mostly of diffuse large B-cell type. The diagnosis of PVRL poses a challenge not only to the clinician, but also to the pathologist. Despite aggressive treatment with chemotherapy and/or radiotherapy, relapses or CNS involvement are common.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.